Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression-Reference-Cited by-同舟云学术

Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression

Published:2019-03-30 Issue:1 Volume:18 Page:
ISSN:1476-4598
Container-title:Molecular Cancer
language:en
Short-container-title:Mol Cancer

Author:

Huang Xiaoxu,Li Zheng,Zhang Qiang,Wang Weizhi,Li Bowen,Wang Lu,Xu Zhipeng,Zeng Ailiang,Zhang Xing,Zhang Xuan,He Zhongyuan,Li Qiang,Sun Guangli,Wang Sen,Li Qing,Wang Linjun,Zhang Lu,Xu Hao,Xu Zekuan^ORCID

Funder

National Natural Science Foundation of China

National Natural Science Foundation Project of International Cooperation

the Primary Research & Development Plan of Jiangsu Province

Priority Academic Program Development of Jiangsu Higher Education Institutions

333 Project of Jiangsu Province

Jiangsu Provincial Key Laboratory of New Environmental Protection

University Natural Science Research Project of Anhui Province

Wannan Medical College Cultivation Fund of the Key Scientific Project

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12943-019-0969-3.pdf

Reference40 articles.

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.

2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.

3. Zhao TT, Xu H, Xu HM, Wang ZN, Xu YY, Song YX, Yin SC, Liu XY, Miao ZF. The efficacy and safety of targeted therapy with or without chemotherapy in advanced gastric cancer treatment: a network meta-analysis of well-designed randomized controlled trials. Gastric Cancer. 2018;21(3):361–71.

4. Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, Miyashita K, Nishizaki T, Kobayashi O, Takiyama W, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008;9(3):215–21.

5. Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3(5):330–8.

Cited by 308 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of spatial omics in gastric cancer;Pathology - Research and Practice;2024-10

2. Novel role of circRNAs in the drug resistance of gastric cancer: regulatory mechanisms and future for cancer therapy;Frontiers in Pharmacology;2024-09-09

3. Role of circRNAs in regulating cell death in cancer: a comprehensive review;Cell Biochemistry and Biophysics;2024-09-07

4. The multifaceted roles of circular RNAs in cancer hallmarks: From mechanisms to clinical implications;Molecular Therapy - Nucleic Acids;2024-09

5. Advanced approaches of the use of circRNAs as a replacement for cancer therapy;Non-coding RNA Research;2024-09